China channel feed – Endpoints News

China channel feed

Ex-Celgene exec steers his biotech startup to Hong Kong IPO as potential cancer drug launch looms

5 years ago

Connect Biopharma snags $115 million in Series C to develop arsenal of immune modulators

5 years ago

Lilly Asia Ventures leads AstraZeneca spinout's $100M push into China's growing R&D hub in Wuxi

5 years ago

Seven PD-(L)1 players could be vying for a place on China's drug reimbursement list. How far will they go?

5 years ago

Teamed up with Lyell, Juno/WuXi joint venture files IPO betting on China's CAR-T future

5 years ago

CanSino reaps $748M windfall from Shanghai IPO — as it warns Covid-19 vaccine won't be a huge money maker

5 years ago

Novartis’ CAR-T partner in China wraps $383M take-private deal engineered by CEO

5 years ago

Perceptive births its first in-house startup — and it's a China play

5 years ago

CAR-T filing in sight, Frank Zhang grabs full control of J&J-partnered Legend Biotech, steps down from GenScript

5 years ago

FBI crackdown on China’s R&D espionage intensifies with new arrests and one fugitive in San Francisco

5 years ago

Houston’s huge R&D hub takes center stage in feds’ campaign to clip China’s ties to researchers, IP theft

5 years ago

Justice Department accuses Chinese hackers of targeting US biotechs in a cybertheft campaign aimed at stealing Covid-19 R&D secrets

5 years ago

Juno/WuXi's cell therapy venture buys out solid tumor player in China, gaining a discovery engine and portending more M&A to come

5 years ago

China's CRO powerhouse Tigermed to seek $1B IPO in Hong Kong — report

5 years ago

China's BeiGene now has $5B+ cash in its coffers. How's the Amgen-partnered biotech going to spend it?

5 years ago

Ophthalmic drugs, cancer cell therapies attract $340M+ on two HKEX biotech debuts

5 years ago

Looking for 'external innovation,' Boehringer Ingelheim reserves $500M+ for new Shanghai hub

5 years ago

Meet the latest genomic data company — aka WuXi NextCODE without the China operations

5 years ago

Chinese vaccine developers have begun to shed some secrecy around Covid-19 candidates. What do we know?

5 years ago

It's not just Charles Lieber: NIH's ongoing investigation has swept up 54 scientists who violated rules about foreign ties

5 years ago

A storied Chinese pharma partner of Bristol Myers, Amgen — and avid biotech supporter — plots HK IPO

5 years ago

Juno, WuXi JV in China score $100M in fresh funding as it sets stage for first CAR-T approval

5 years ago

Sanofi sharpens focus on bispecifics, and China, with Alphamab deal

5 years ago

Harvard's Charles Lieber indicted for lying to the feds, bringing US researchers' China ties back to the spotlight

5 years ago

First page Previous page 15 16 171819 20 21 Next page Last page